FDA Approves Merck’s RSV Shot for Infants, Boosting Competition with Sanofi and AstraZeneca
Merck’s RSV shot for infants gets FDA approval, setting up a competitive clash with Sanofi and AstraZeneca’s Beyfortus in the health market.
Read MoreFDA Approves Merck’s RSV Shot for Infants, Boosting Competition with Sanofi and AstraZeneca